| | |
Plasma VEGF Levels, pg/mL
|
|---|
|
Characteristics
|
No. (%)
|
Median
|
25-75% Quartile
|
p Value
|
|---|
|
Age
| | | | |
|
<60
|
79 (59)
|
267.4
|
169.5 - 454.0
|
0.465
|
|
>60
|
55 (41)
|
262.7
|
146.6-385.4
| |
|
Sex
| | | | |
|
Male
|
121 (90.3)
|
264.0
|
154.0 - 392.6
|
0.151
|
|
Female
|
13 (9.7)
|
338.4
|
262.0 - 459.4
| |
|
Smoking
| | | | |
|
Smokers
|
108 (80.6)
|
273.9
|
173.7 - 442.7
|
0.144
|
|
Never-smokers
|
26 (19.4)
|
257.1
|
120.7 - 354.5
| |
|
ECOG
| | | | |
|
1
|
39 (29.1)
|
225.7
|
108.6 - 354.5
|
0.062
|
|
2-3
|
95 (70.9)
|
282.0
|
182.3 - 446.0
| |
|
Histology
| | | | |
|
SCC
|
103 (76.9)
|
276.0
|
169.5 - 439.5
|
0.147
|
|
ADC
|
31 (23.1)
|
262.0
|
132.3 - 338.4
| |
|
Stage
| | | | |
|
III
|
87 (64.9)
|
251.4
|
149.0 - 433.4
|
0.250
|
|
IV
|
47 (35.1)
|
276.0
|
214.0 - 399.4
| |
|
Tumor Size
| | | | |
|
<3 cm
|
44 (32.8)
|
172.4
|
93.0 - 262.0
|
0.001
|
|
>3 cm
|
90 (67.2)
|
339.9
|
218.0 - 484.5
| |
|
T Factor
| | | | |
|
T2-T3
|
66 (49.2)
|
270.9
|
149.0 - 379.0
|
0.653
|
|
T4
|
68 (50.8)
|
263.0
|
157.6 - 439.7
| |
|
N Factor
| | | | |
|
N0-N1
|
65 (48.5)
|
245.7
|
121.4 - 360.7
|
0.082
|
|
N2-N3
|
69 (51.5)
|
285.7
|
192.0-439.5
| |
|
M Factor
| | | | |
|
M0
|
87 (64.9)
|
251.4
|
149.0 - 433.4
|
0.250
|
|
M1
|
47 (35.1)
|
276.0
|
214.0 - 399.4
| |
|
Tobacco
| | | | |
|
Yes
|
25 (18.7)
|
252.3
|
185.7 - 354.5
|
0.524
|
|
No
|
109 (81.3)
|
267.4
|
154.0 - 433.4
| |
- VEGF, vascular endothelial growth factor; ECOG, Eastern Cooperative Oncology Group; NSCLC, non-small cell lung cancer; SCC, squamous cell carcinoma; ADC, adenocarcinoma; T, tumor; N, node; M, metastasis
